2025 annual financial data
Lyell Immunopharma 2025 Financial results
Direct answer
Revenue was 36,000 USD.
Operating income was -203.77M USD and net income was -274.45M USD.
Operating cash flow was -150.02M USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,000 USD
- Operating income
- -203.77M USD
- Net income
- -274.45M USD
- Operating cash flow
- -150.02M USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lyell Immunopharma financial years